A challenging case of serum vasoactive intestinal peptide‐negative vasoactive intestinal peptide‐secreting tumour as cause of severe chronic diarrhoea

Documenti analoghi

• Collagen and microvascular alterations contribute to neuromuscular degeneration and disease progression in chronic intestinal pseudo‐obstruction
  di: Elisa Boschetti, et al.
  Pubblicazione: (2026)
• Therapeutic innovations to counter antimicrobial‐resistant infections and antimicrobial peptides
  di: Antonio Vitiello
  Pubblicazione: (2025)
• Depression following the initiation of glucagon‐like‐peptide‐1 receptor agonist therapy: A multinational self‐controlled case series study
  di: Vincent Ka Chun Yan, et al.
  Pubblicazione: (2026)
• Glucagon‐like peptide‐1 agonists for treating substance use disorders: ready for clinical use?
  di: Grace Meulman, et al.
  Pubblicazione: (2026)
• Distribution of vasoactive intestinal peptide (VIP) immunoreactivity in the rat pallial and subpallial amygdala and colocalization with γ‐aminobutyric acid (GABA)
  di: G. Salamanca, et al.
  Pubblicazione: (2024)